On monoaminergic interaction with behaviour-modifying peptide hormones.
D000342:Affective Symptoms / Q000503:physiopathology*; D000818:Animals; D014150:Antipsychotic Agents / Q000494:pharmacology; D001522:Behavior, Animal / Q000187:drug effects; D001679:Biogenic Amines / Q000378:metabolism; D006801:Humans; D007031:Hypothalamus / Q000503:physiopathology*; D010903:Pituitary Gland, Anterior / Q000503:physiopathology*; D011388:Prolactin / Q000502:physiology; D051381:Rats; D017981:Receptors, Neurotransmitter / Q000378:metabolism / Q000502:physiology; D013881:Thioridazine / Q000494:pharmacology
D014150:Antipsychotic Agents; D001679:Biogenic Amines; D017981:Receptors, Neurotransmitter; D011388:Prolactin; D013881:Thioridazine